Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
The polycystic kidney disease drugs market was valued at USD 0.51 billion in 2024, driven by rising incidence of autosomal dominant polycystic kidney disease across the 8 major markets. The market is expected to grow at a CAGR of 5.90% during the forecast period of 2025-2034, with the values likely to reach USD 0.86 billion by 2034.
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
- The market growth is fueled by increasing collaborative efforts between pharmaceutical firms and research institutions to spur advanced therapies targeting polycystic kidney disease (PKD) mechanisms.
- Increasing incidence of drugs FDA approvals for treating polycystic kidney disease is amongst the major market trends.
- Technological innovations in drug development, like high-throughput screenings and personalized medicine are expected to fuel the demand for polycystic kidney disease drugs in the forecast period.
Leading Players in the Polycystic Kidney Disease Drugs Market
They key features of the market report include patent analyses, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd, headquartered in Basel, Switzerland, was founded in 1896. The company specializes in pharmaceutical manufacturing and is a leader in the field of cancer drug development and sales. Roche has developed drugs and diagnostics for various disease, including PKD-1 inhibitors. Some of the drugs include Mycophenolate Mofetil (Cellcept), and Valganciclovir (Valcyte).
Galapagos NV
Galapagos NV, founded in 1999 as a joint venture between Crucell and Tibotec, is headquartered in Mechelen, Belgium. The company specializes in pharmaceutical research and is developing GLPG2737, a CFTR1 inhibitor to treat polycystic kidney disease (ADPKD).
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. was established in 1886 in New Brunswick. The company is developing JNJ-0237, an oral medication to treat ADPKD.
Merck and Co. Inc.
Merck and Co. Inc. was founded in 1891, in New York. The company is amongst the leading companies in pharmaceutical development and boasts an elaborate drugs portfolio for a variety of diseases including polycystic kidney disease.
Other companies in the market include AbbVie Inc., Apotex Inc., Amgen Inc., Otsuka Holdings Co. Ltd., Palladio Biosciences Inc., Regulus Therapeutics, Sanofi SA, XORTX Therapeutics Inc., Novartis AG, Teva Pharmaceutical Industries Ltd, and Bayer AG
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Polycystic Kidney Disease Drugs Market Report Snapshots
Polycystic Kidney Disease Drugs Market Size
Polycystic Kidney Disease Drugs Market Growth
Polycystic Kidney Disease Drugs Market Trends
Polycystic Kidney Disease Drugs Market Share
Polycystic Kidney Disease Drugs Market Regional Analysis
Polycystic Kidney Disease Drugs Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124